BioPlus Co., Ltd
KOSDAQ
₩3,220.00
+0.00%
Delayed · cached 15 min
Fair value analysis
099430
BioPlus Co., Ltd
₩3,220.00
Close used for this calculation
₩4,284.75Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
50/100
Quality radar
Consensus fair value
₩4,284.75
Below FV▲ +33.1% against the close used
Model range ₩1,837.96 – ₩14,329.92
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩1,837.96Fair value₩4,284.75Bull₩14,329.92
FairClose
52-week traded range
52W low ₩3,220.0052W high ₩7,200.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
BioPlus Co., Ltd closed at ₩3,220.00, 24.8% below the consensus fair value of ₩4,284.75 drawn from 10 valuation models.
Financial DNA score 50/100 — Good. P/E of 12.7x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩5,021.80
+56.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩4,027.54
+25.1%
√(22.5 × EPS × BVPS)
EPS=253, BVPS=2849.56
Graham Formula
₩14,329.92
+345.0%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=17%, FD=3.3%
P/E Fair Value
₩5,060.00
+57.1%
EPS × 20x (sector P/E)
EPS=253, Sector P/E=20x
Peter Lynch (PEG)
₩4,298.47
+33.5%
EPS × Growth% (PEG = 1 is fair)
EPS=253, g=17%
EV/EBITDA
₩3,417.33
+6.1%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=15.01B
Dividend Discount (DDM)
₩2,434.32
-24.4%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=45.08, r=10%, g=8%
Book Value (P/B)
₩1,837.96
-42.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=2849.56, ROE=8.6%, g=6%, r=10%
Reverse DCF
₩3,220.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 1% | Historical: 17%
Margin of Safety
₩5,332.36
+65.6%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=7109.82, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.